Allergic disease
MONDO:0005271An immune response that occurs following re-exposure to an innocuous antigen, and that requires the presence of existing antibodies against that antigen. This response involves the binding of IgE to mast cells, and may worsen with repeated exposures.
Also known as: allergic disease or disorder, allergic form of disease or disorder, allergic form of immune system disease, allergic reaction, allergic response, allergy, disorder of type I hypersensitivity, type I hypersensitivity disease
966 clinical trials for this condition and its sub-types, 178 tagged with Allergic disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Allergic disease
-
Atopic eczema 467 trials · 480 incl. sub-types
3 sub-types
- Allergic contact dermatitis 10 trials Sub-types →
- Allergic urticaria 3 trials · 5 incl. sub-types Sub-types →
- Allergic cutaneous vasculitis 1 trial
-
Allergic respiratory disease 2 trials · 218 incl. sub-types
4 sub-types
- Allergic rhinitis 96 trials · 140 incl. sub-types Sub-types →
- Allergic asthma 41 trials Sub-types →
- Hypersensitivity pneumonitis 25 trials · 30 incl. sub-types Sub-types →
- Allergic bronchopulmonary aspergillosis 15 trials Sub-types →
-
Food allergy 115 trials
-
Drug allergy 35 trials
-
Eye allergy 2 trials · 20 incl. sub-types
2 sub-types
- Atopic conjunctivitis 19 trials Sub-types →
- Allergic contact dermatitis of eyelid 0 trials
-
Atopic IgE-mediated allergic disorder 13 trials
-
Venom allergy 12 trials
-
Gastrointestinal allergy 0 trials · 5 incl. sub-types
1 sub-type
-
Alpha-gal syndrome 4 trials
-
Allergic otitis media 0 trials
1 sub-type
- Acute allergic serous otitis media 0 trials
-
Latex allergy 0 trials
-
Vulvovaginitis, allergic seminal 0 trials
Most studied deeper sub-types
-
Experimental asthma drug briquilimab fails to reach Late-Stage testing
Disease control Stopped earlyThis Phase 1 trial tested a single dose of briquilimab in 17 adults with mild-to-moderate allergic asthma to see if it was safe and could reduce asthma attacks triggered by allergens. The study was terminated early, meaning it did not continue as planned. The main goal was to che…
Phase 1 • Sponsor: Jasper Therapeutics, Inc. • Aim: Disease control
Last updated Jun 26, 2026 18:40 UTC
-
Hay fever education trial fizzles out: did extra lessons help?
Symptom relief Stopped earlyThis study tested whether teaching teens and young adults (ages 14-29) the correct way to use nasal sprays for hay fever would improve their symptoms compared to standard care. The trial was terminated early and enrolled only 18 participants. The goal was to see if repeat educati…
Sponsor: Murdoch Childrens Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Can hand exercises and electrical stimulation ease MS sensory problems?
Symptom relief Stopped earlyThis study tested a rehabilitation program for hand sensitivity problems in people with multiple sclerosis. The program used TENS (a mild electrical stimulation device) and hand exercises to improve the ability to feel and recognize objects. The goal was to improve quality of lif…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
Nickel allergy and knee surgery: no big difference found?
Knowledge-focused Stopped earlyThis study looked at whether people with nickel allergy do better with special nickel-free knee implants. Researchers compared standard implants to nickel-free ones in 9 patients with self-reported nickel sensitivity. The goal was to see if nickel allergy affects pain, function, …
Sponsor: Rush University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC